Cargando…
New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: A review of 671 cases
“Meningoencephalomyelitis of unknown origin” (MUO)—a collective term for a group of clinically-indistinguishable (but pathologically distinct) autoimmune diseases of the CNS—has become increasingly commonly recognized throughout the world. In the 1960s−1980s the focus was primarily on the pathologic...
Autores principales: | Jeffery, Nick, Granger, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050685/ https://www.ncbi.nlm.nih.gov/pubmed/37008358 http://dx.doi.org/10.3389/fvets.2023.1114798 |
Ejemplares similares
-
Perspectives on pharmacologic strategies in the management of meningoencephalomyelitis of unknown origin in dogs
por: Beasley, Michaela J., et al.
Publicado: (2023) -
Differential T-cell responses in dogs with meningoencephalomyelitis of unknown origin compared to healthy controls
por: Barber, Renee, et al.
Publicado: (2022) -
Meningoencephalomyelitis of Unknown Origin in Cats: A Case Series Describing Clinical and Pathological Findings
por: Nessler, Jasmin, et al.
Publicado: (2020) -
Treatment With Cytarabine at Initiation of Therapy With Cyclosporine and Glucocorticoids for Dogs With Meningoencephalomyelitis of Unknown Origin Is Not Associated With Improved Outcomes
por: Barber, Renee, et al.
Publicado: (2022) -
Case Report: Meningoencephalomyelitis of Unknown Etiology Manifesting as a Bilateral Cranial Polyneuropathy in 3 Dogs
por: Levitin, Hilary A., et al.
Publicado: (2020)